Sarepta Therapeutics (SRPT) Capital Expenditures Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -39.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.69% |
| Dec 31, 2025 | -23.32% |
| Sep 30, 2025 | 40.72% |
| Jun 30, 2025 | 51.87% |
| Mar 31, 2025 | 98.86% |
| Dec 31, 2024 | 158.45% |
| Sep 30, 2024 | 59.17% |
| Jun 30, 2024 | 70.41% |
| Mar 31, 2024 | 15.33% |
| Dec 31, 2023 | -12.69% |
| Sep 30, 2023 | 5.45% |
| Jun 30, 2023 | -2.24% |
| Mar 31, 2023 | 1.32% |
| Dec 31, 2022 | -22.72% |
| Sep 30, 2022 | -4.43% |
| Jun 30, 2022 | -18.36% |
| Mar 31, 2022 | -30.11% |
| Dec 31, 2021 | -52.20% |
| Sep 30, 2021 | -22.81% |
| Jun 30, 2021 | -12.16% |
| Mar 31, 2021 | 20.24% |
| Dec 31, 2020 | 94.32% |
| Sep 30, 2020 | 221.00% |
| Jun 30, 2020 | 88.30% |
| Mar 31, 2020 | 26.88% |
| Dec 31, 2019 | 80.92% |
| Sep 30, 2019 | 123.90% |
| Jun 30, 2019 | 241.46% |
| Mar 31, 2019 | 140.58% |
| Dec 31, 2018 | 165.05% |
| Sep 30, 2018 | 159.70% |
| Jun 30, 2018 | 139.01% |
| Mar 31, 2018 | 183.84% |
| Dec 31, 2017 | 7.49% |
| Sep 30, 2017 | -60.55% |
| Jun 30, 2017 | -14.01% |
| Mar 31, 2017 | -5.71% |
| Dec 31, 2016 | 68.60% |
| Sep 30, 2016 | -14.14% |
| Jun 30, 2016 | -0.55% |
| Mar 31, 2016 | 406.29% |
| Sep 30, 2015 | 226.39% |
| Jun 30, 2015 | 68.14% |
| Mar 31, 2015 | 289.54% |
| Dec 31, 2014 | 148.32% |
| Sep 30, 2014 | 247.51% |
| Jun 30, 2014 | 115.84% |
| Mar 31, 2014 | 186.28% |
| Dec 31, 2013 | 43.91% |
| Sep 30, 2013 | 66.40% |